MYVAL Transcatheter Heart Valve - ARCSA Registration 7b5982ccebcc71e49d10fc5999e07c1b
Access comprehensive regulatory information for MYVAL Transcatheter Heart Valve in the Ecuador medical device market through Pure Global AI's free database. This IV medical device is registered under ARCSA ID 7b5982ccebcc71e49d10fc5999e07c1b and manufactured by MERIL LIFE SCIENCES PVT LTD. The device was registered on February 21, 2020.
This page provides complete registration details including product type (Invasive), manufacturer information, authorized representative details, and regulatory compliance data from the official Ecuador ARCSA medical device database. Pure Global AI offers free access to Ecuador's complete medical device registry.
THE MYVALTM TRANSCATHETER HEART VALVE (THV) AND ACCESSORIES ARE INDICATED FOR RELIEF OF AORTIC STENOSIS IN PATIENTS WITH SYMPTOMATIC HEART DISEASE DUE TO SEVERE NATIVE CALCIFIC AORTIC STENOSIS AS JUDGED BY A HEART TEAM (INCLUDING A CARDIAC SURGEON) AND IN PATIENTS WHO ARE AT HIGH RISK FOR OPEN HEART SURGICAL THERAPY